This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-19 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Eivor Örnskov, Ph.D.
Associate Principal Scientist, Pharmaceutical at AstraZeneca Gothenburg


Dr. Eivor Örnskov received a PhD in Analytical Chemistry in 2004 from Uppsala University, Sweden. At AstraZeneca Gothenburg Sweden, Eivor has developed numerous stability indicating Liquid Chromatography and Capillary Electrophoresis methods for use in pre-clinical and clinical phase. In her current position, Eivor is responsible for development of the analytical platform for large RNA and coordinate the analytical contributions in clinical mRNA projects within AstraZeneca Gothenburg. Furthermore, Eivor has written CMC parts of regulatory submissions and published research papers in the area of polynucleotide and mRNA separations.

Agenda Sessions

  • Control Strategies for Early Clinical Phase mRNA Projects